Viewing entries in
dementia

Gossypetin in hibiscus, Alzheimer's

Gossypetin in hibiscus, Alzheimer's

A November 2022 study by the Department of Life Sciences, POSTECH said

“We have confirmed that removing Aβ aggregates deposited in the brain is effective in preventing and treating dementia. Gossypetin from hibiscus will contribute to the development of a safe and affordable drug for patients suffering from AD.” 

Calculating the risk of dementia

Calculating the risk of dementia

A June 2022 study by The Ottawa Hospital, the University of Ottawa, the Bruyère Research Institute and ICES said

  • "What sets this dementia risk calculator apart is that you don't need to visit a doctor for any tests," 

  • "People already have all the information they need to complete the calculator in the comfort of their home." 

  • "This tool will give people who fill it out clues to what they can do to reduce their personal risk of dementia," 

  • "The COVID-19 pandemic has also made it clear that sociodemographic variables like ethnicity and neighbourhood play a major role in our health. It was important to include those variables in the tool so policy makers can understand how different populations are impacted by dementia, and help ensure that any prevention strategies are equitable."

Sauna and Dementia

Sauna and Dementia

A February 2016 study of men by the University of Eastern Finland said those having a sauna 4-7 times each week were 66% less likely to be diagnosed with dementia than those taking a sauna once each week.

Midlife loneliness, Dementia and Alzheimer's

Midlife loneliness, Dementia and Alzheimer's

A March 2021 study by the Boston University School of Medicine said, 

"Whereas persistent loneliness is a threat to brain health, psychological resilience following adverse life experiences may explain why transient loneliness is protective in the context of dementia onset," 

Visceral Fat, Cognition and Diabetes

Visceral Fat, Cognition and Diabetes

In a February 2020 study it was said, "Preserved cognitive functioning is important in the execution of complex task such as diabetes self-care management. Therefore, assessment of visceral adiposity and interventions that target visceral adiposity may help to prevent cognitive decline in older patients with diabetes and reduce the global burden of dementia in ageing populations,"

Aerobic Exercise and Alzheimer’s

Aerobic Exercise and Alzheimer’s

A February 2020 study by the University of Wisconsin School of Medicine and Public Health said,

“This study is a significant step toward developing an exercise prescription that protects the brain against [Alzheimer’s], even among people who were previously sedentary," 

"This research shows that a lifestyle behavior - regular aerobic exercise - can potentially enhance brain and cognitive functions that are particularly sensitive to the disease. The findings are especially relevant to individuals who are at a higher risk due to family history or genetic predisposition,"

"An important next step would be to conduct a larger, more definitive, study. If these findings are replicated, they would have a tremendous impact on quality of later life, providing individuals with more years of independent living, active engagement with loved ones, and building memories."

 

Blood Pressure and Dementia

Blood Pressure and Dementia

An August 2019 study by Johns Hopkins University School of Medicine suggests that, "one's blood pressure during midlife may influence how blood pressure later in life relates to dementia risk … [and] individuals with high blood pressure in midlife may benefit from targeting their blood pressure to normal levels in later life, as having blood pressure that is too high or too low in late life may further increase dementia risk."

 

Statins and Dementia

Statins and Dementia

A July 2019 report by University Medical Center Ljubljana, Slovenia and the Karolinska Institutet, Sweden finds that, “…the use of statins is significantly associated with a reduction in the risk of mortality in dementia patients” and that, “…statin users had a 23% reduction in the risk of stroke, which is three times more likely in patients with mild dementia and seven times more likely in those with severe dementia.”

Dr Sara Garcia-Ptacek said, "This is a cohort study, which means patients were not randomized to a treatment like they would be in a clinical trial. For this reason, we can only show an association, and not definitely prove that statins caused this decline in mortality. However, our results are encouraging and suggest that patients with dementia benefit from statins to a similar extent than patients without dementia."